- Home
- GOVX vs CPOP Comparison
GOVX vs CPOP Comparison
Compare GOVX & CPOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | CPOP |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 36.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GOVX | CPOP |
|---|---|---|
| Price | $0.37 | $0.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 547.9K | ★ 739.3K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,353,560.00 | ★ $107,632,769.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 8.52 | ★ 127.16 |
| 52 Week Low | $0.37 | $0.39 |
| 52 Week High | $2.75 | $2.61 |
Technical Indicators
Market Signals| Indicator | GOVX | CPOP |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 40.75 |
| Support Level | $0.37 | $0.40 |
| Resistance Level | $0.41 | $0.44 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 12.10 | 52.06 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.